MedTrace Logo

Eye Plaque Brachytherapy for Ocular Melanoma

NCT06432660 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2026-02-06

No results posted yet for this study

Summary

This prospective registry study will evaluate doses utilized in eye plaque brachytherapy for the treatment of ocular melanoma and their associated outcomes. The goal of this study is to evaluate if lower doses of radiation can maintain high local control rates while minimizing the toxicities related to radiation therapy.

Conditions

  • Ocular Melanoma

Interventions

OTHER

Data collection

Information about radiation therapy via eye plaque brachytherapy and follow up

Sponsors & Collaborators

Principal Investigators

  • Dianda Ayala-Peacock, MD · Duke University Health System (DUHS)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-03
Primary Completion
2029-09-30
Completion
2029-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06432660 on ClinicalTrials.gov